Factor Viii Replacement
Factor VIII Replacement is a therapeutic intervention involving the administration of exogenous Factor VIII to correct deficient or impaired endogenous Factor VIII activity in individuals with hemophilia A or other Factor VIII-deficient states.
1.1K
Publications
59.9K
Citations
4.1K
Authors
1.3K
Institutions
Publications per year
2017–2026
184
Variants
Factor Viii Replacement Therapy
Parents
1.1K
WFH Guidelines for the Management of Hemophilia, 3rd edition
Alok Srivastava, Elena Santagostino, Alison Dougall et al. · Haemophilia · 2020 · 1.9K citations · Full text
G C White, Frits R. Rosendaal, Louis M. Aledort et al. · PubMed · 2001 · 803 citations
Medicine, Hematology, Hemostasis +15
1–5 of 1.1K
4.1K
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy
33 publications · 4.7K citations
25
h-index
23
h-index
23
h-index
22
h-index
19
h-index
1–5 of 4.1K
1.3K

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
34 h-index
159 publications
31.6K citations

University of Milan
Milan, Italy
28 h-index
101 publications
9.2K citations

Lund University
Lund, Sweden
28 h-index
63 publications
6.3K citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
26 h-index
89 publications
9.4K citations
University College London
London, United Kingdom
24 h-index
78 publications
7.9K citations
University Medical Center Utrecht
Utrecht, The Netherlands
24 h-index
75 publications
6.9K citations
Hospital for Sick Children
Toronto, Canada
22 h-index
69 publications
7.3K citations

Novo Nordisk (Denmark)
Copenhagen, Denmark
22 h-index
70 publications
4.7K citations
1–8 of 1.3K
105 publications · 11K citations
57
h-index
236 publications · 10.5K citations
50
h-index
JTH · 74 publications · 4.7K citations
40
h-index
65 publications · 3K citations
29
h-index
Repository · 92 publications · 3.5K citations
27
h-index
1–5